Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antirheumatic Agents”

128 trials

Showing 20 of 128 results

Post-approval studies (Phase 4)Study completedNCT01511003
What this trial is testing

A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 128
Testing effectiveness (Phase 2)Looking for participantsNCT05149768
What this trial is testing

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Not applicableStudy completedNCT01166763
What this trial is testing

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

Who this might be right for
Breast Cancer
Carol Fabian, MD 30
Testing effectiveness (Phase 2)Study completedNCT00147498
What this trial is testing

Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks

Who this might be right for
Rheumatoid Arthritis
Pfizer 264
Large-scale testing (Phase 3)Study completedNCT01711359
What this trial is testing

A Study in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 588
Not applicableStudy completedNCT01137851
What this trial is testing

Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 3,940
Large-scale testing (Phase 3)Study completedNCT01604343
What this trial is testing

CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 1,670
Large-scale testing (Phase 3)Study completedNCT04134728
What this trial is testing

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 550
Early research (Phase 1)Study completedNCT00902460
What this trial is testing

CP-690,550 and Midazolam Drug-Drug Interaction Study

Who this might be right for
Healthy Volunteer
Pfizer 25
Not applicableLooking for participantsNCT05003310
What this trial is testing

ConsideRAte Study - Splenic Stimulation for RA

Who this might be right for
Rheumatoid Arthritis
Galvani Bioelectronics 28
Not applicableStudy completedNCT01095393
What this trial is testing

National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 12,500
Large-scale testing (Phase 3)Study completedNCT02706951
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

Who this might be right for
Rheumatoid Arthritis
AbbVie 648
Large-scale testing (Phase 3)Study completedNCT00856544
What this trial is testing

A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications

Who this might be right for
Arthritis, Rheumatoid
Pfizer 795
Not applicableLooking for participantsNCT01581294
What this trial is testing

The Norwegian Antirheumatic Drug Register

Who this might be right for
Inflammatory Joint Diseases
Diakonhjemmet Hospital 15,000
Post-approval studies (Phase 4)Study completedNCT02433184
What this trial is testing

Very Early Versus Delayed Etanercept in Patients With RA

Who this might be right for
Rheumatoid Arthritis
University of Leeds 120
Large-scale testing (Phase 3)Study completedNCT02675426
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone

Who this might be right for
Rheumatoid Arthritis
AbbVie 661
Large-scale testing (Phase 3)Study completedNCT01519791
What this trial is testing

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA 880
Early research (Phase 1)Study completedNCT01137708
What this trial is testing

CP-690,550 And Oral Contraception Drug-Drug Interaction Study

Who this might be right for
Healthy
Pfizer 20
Large-scale testing (Phase 3)Study completedNCT00503425
What this trial is testing

MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 215
Large-scale testing (Phase 3)Active Not RecruitingNCT06276998
What this trial is testing

LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)

Who this might be right for
Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd 430
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation